Nebulized Drug Delivery in Respiratory Medicine: What Does the Future Hold?
Overview
Authors
Affiliations
In the later half of the 20th century, nebulized therapy was in decline, but in the 21st century the prospects for the expanded use of nebulized therapy within respiratory medicine look bright. The advent of mesh nebulizers, which combine the universal applicability of the nebulizer in the treatment of all respiratory patients with the convenience of portable inhaler use, is ideally timed to capitalize on the forecast of increased numbers of patients who will require nebulized therapy in the future. This special report will highlight some of the opportunities that the development of mesh nebulizers presents in the field of respiratory medicine.
Towards More Precise Targeting of Inhaled Aerosols to Different Areas of the Respiratory System.
Sosnowski T Pharmaceutics. 2024; 16(1).
PMID: 38258107 PMC: 10818612. DOI: 10.3390/pharmaceutics16010097.
Evaluation of Aerosol Therapy during the Escalation of Care in a Model of Adult Cystic Fibrosis.
Fernandez Fernandez E, Joyce M, OSullivan A, MacLoughlin R Antibiotics (Basel). 2021; 10(5).
PMID: 33919035 PMC: 8142975. DOI: 10.3390/antibiotics10050472.
Hvisdas C Am J Health Syst Pharm. 2021; 78(13):1184-1194.
PMID: 33821890 PMC: 8083528. DOI: 10.1093/ajhp/zxab154.
Zhang R, Hu J, Deng L, Li S, Chen X, Liu F Pharmaceutics. 2020; 12(1).
PMID: 31963493 PMC: 7023084. DOI: 10.3390/pharmaceutics12010078.
Ferguson G, Feldman G, Pudi K, Barnes C, Moran E, Haumann B Chronic Obstr Pulm Dis. 2019; 6(2):154-165.
PMID: 30974049 PMC: 6596436. DOI: 10.15326/jcopdf.6.2.2018.0152.